Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P36217 (XYN2_HYPJR) Hypocrea jecorina (strain ATCC 56765 / BCRC 32924 / NRRL 11460 / Rut C-30)(Trichoderma reesei)

Endo-1,4-beta-xylanase 2 UniProtKBInterProInteractive Modelling

223 aa; Sequence (Fasta) ; 1 identical sequence: Hypocrea jecorina: G0RUP7

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
X-ray structure analysis of xylanase-WT at pH4.0homo-2-mer35-223
IOD;TRS;
Assess
X-ray structure analysis of xylanase - N44Dhomo-2-mer36-223
IOD;
Assess
Xylanase II from Tricoderma reesei at 100Kmonomer34-223
SO4;IOD;
Assess
Xylanase II from Tricoderma reesei at 293Kmonomer34-223
IOD;
Assess
Improved ligand discovery using micro-beam data collection at the edge of protein crystalsmonomer34-223
ARG;NA;EDO;
Assess
STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEImonomer34-223
Assess
STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEImonomer34-223
Assess
STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEImonomer34-223
Assess
ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 4,5-EPOXYPENTYL-BETA-D-XYLOSIDEmonomer34-223
Assess
ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 3,4-EPOXYBUTYL-BETA-D-XYLOSIDEmonomer34-223
Assess
ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 2,3-EPOXYPROPYL-BETA-D-XYLOSIDEmonomer34-223
Assess
Joint X-ray/neutron structure of Trichoderma reesei xylanase II at pH 8.5monomer34-223
IOD;
Assess
Joint X-ray/neutron structure of Trichoderma reesei xylanase II at pH 5.8monomer34-223
IOD;
Assess
Joint X-ray/neutron structure of Trichoderma reesei xylanase II in complex with MES at pH 5.7monomer34-223
IOD;MES;
Assess
Joint X-ray/neutron structure of Trichoderma reesei xylanase II at pH 4.4monomer34-223
IOD;
Assess
MicroED structure of xylanase at 2.3 A resolutionmonomer34-223
IOD;
Assess
Crystal Structure Analysis of Proteinmonomer35-223
GOL;IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase IImonomer35-223
GOL;IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II Complexed with substrate (1.15 A) and Produc…monomer35-223
IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
GOL;IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II (Y88F)monomer35-223
IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;MES;IOD;
Assess
Crystal Structures of Mutant Endo- -1,4-xylanase II Complexed with substrate (1.15 A) and Products …monomer35-223
XYP;GOL;CIT;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;GOL;IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;GOL;IOD;
Assess
Crystal Structure Analysis of Proteinmonomer35-223
XYP;IOD;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;XYP;GOL;IOD;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
GOL;IOD;
Assess
Crystal Structure Analysis of Endo-beta-1,4-Xylanase II Complexed with Xylotriosemonomer35-223
XYP;GOL;IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II (Y88F)Complexed with Xylotriosemonomer35-223
XYP;IOD;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase IImonomer35-223
GOL;IOD;
Assess
Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase(Y77F)monomer35-223
IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II(Y77F) Complexed with Xylotriosemonomer35-223
XYP;GOL;IOD;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II (E177Q) in the apo formmonomer35-223
IOD;
Assess
X-ray structure analysis of xylanase-N44E with MES at pH6.0monomer35-223
IOD;MES;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
GOL;IOD;
Assess
Xylanase II from Trichoderma reesei cocrystallized with tris-dipicolinate europiummonomer35-223
EU;PDC;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II Complexed with Substrate and Productsmonomer35-223
XYS;XYP;TRS;CA;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;IOD;
Assess
Crystal Structure Analysis of Endo-beta-1,4-xylanase II Complexed with Xylotriosemonomer35-223
XYP;IOD;
Assess
Structure of VIL (extra KI/I2 added)-xylanasemonomer35-223
IOD;
Assess
Structure of VIL-xylanasemonomer35-223
Assess
Neutron structure of xylanase at pD5.4monomer35-223
Assess
Neutron and X-ray structure analysis of xylanase: N44D at pH6monomer35-223
IOD;
Assess
Crystal Structures of Mutant Endo-beta-1,4-xylanase II Complexed with substrate (1.15 A) and Produc…monomer36-223
XYP;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1xyp.2.Amonomer0.9334-223
100.00
Assess